Schizoaffective Disorder
📧 Sign up to get email alerts when something new happens for Schizoaffective Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Neural Oscillations as Genetic and Functional Biomarkers in Normal and Disease States
Completed clinical trial investigating neural oscillations as genetic and functional biomarkers across normal and disease states, including …
-
FDA approval · 2024-03-21FDA Approved: PALIPERIDONE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal's supplemental application for Paliperidone, enabling the marketing of a generic paliperidone product. This is an admini…
-
CLINICAL_TRIALS trial_result · 2024-02-08Clinical Trial Update: Varenicline Treatment in Alcohol and Nicotine Dependent Patients With Schizophrenia [Phase 4]
Phase 4 clinical trial evaluating varenicline for individuals with schizophrenia or schizoaffective disorder who are also dependent on alcoh…
-
CLINICAL_TRIALS trial_result · 2023-11-28Clinical Trial Update: Bazedoxifene -Treatment for Women With Schizophrenia [Phase 4]
Phase 4 clinical trial investigating bazedoxifene as a treatment for schizophrenia-related conditions.
-
CLINICAL_TRIALS trial_result · 2023-11-28Clinical Trial Update: Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode [Phase 4]
Phase 4 trial updating on aripiprazole lauroxil for preventing psychotic relapse after an initial schizophrenia episode; terminated with res…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-11-28Clinical Trial Update: Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men? [Phase 4]
Phase 4 trial investigating selective estrogen receptor modulators (SERMs) as a potential treatment for psychotic symptoms in men with schiz…
-
CLINICAL_TRIALS trial_result · 2023-10-23Clinical Trial Update: Evaluating Sublingual Dexmedetomidine For Moderate To Severe Agitation In Inpatients With Schizophrenia Or Bipolar Disorder [Phase 4]
Phase 4 clinical trial evaluating sublingual dexmedetomidine for moderate to severe agitation in inpatients with schizophrenia or bipolar di…
-
CLINICAL_TRIALS trial_result · 2023-10-10Clinical Trial Update: A Trial of the Efficacy and the Safety of RO6889450 (Ralmitaront) vs Placebo in Patients With an Acute Exacerbation of Schizophrenia or Schizoaffective Disorder [Phase 2]
Phase 2 trial evaluating the efficacy and safety of RO6889450 (ralmitaront) versus placebo in acute exacerbations of schizophrenia or schizo…
-
FDA approval · 2023-09-21FDA Approved: PALIPERIDONE — Supplemental Application (NorthStar RxLLC)
FDA approved a supplemental application for paliperidone filed by NorthStar RxLLC under ANDA205618.
-
CLINICAL_TRIALS trial_result · 2023-09-07Clinical Trial Update: Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia [Phase 4]
Phase 4 trial update evaluating switching from twice-daily to once-daily clozapine dosing in schizophrenia and schizoaffective disorder.
-
FDA approval · 2023-09-05FDA Approved: PALIPERIDONE — Supplemental Application (Tris Pharma Inc)
FDA granted a supplemental approval for a generic paliperidone product from Tris Pharma Inc (ANDA 212807).
-
FDA approval · 2023-08-23FDA Approved: PALIPERIDONE — Original Application (Camber Pharmaceuticals, Inc)
FDA approved Camber Pharmaceuticals' generic paliperidone through original application, enabling a new generic option for this antipsychotic…
-
CLINICAL_TRIALS research · 2023-06-22Clinical Trial Update: Novel Pharmacotherapy Approaches in Smokers With Serious Mental Illness [Phase 4]
Phase 4 trial update on novel pharmacotherapy approaches for nicotine dependence in smokers with serious mental illness, completed with post…
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia [Phase 3]
Phase 3 trial assessing dexmedetomidine for agitation in schizophrenia completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Prebiotic Treatment in People With Schizophrenia - Pilot Study [Phase 4]
Phase 4 pilot trial evaluating prebiotic treatment in people with schizophrenia and schizoaffective disorder; completed with results posted …
-
CLINICAL_TRIALS trial_result · 2023-05-25Clinical Trial Update: Models of Auditory Hallucination [NA]
A clinical trial studying models of auditory hallucination in individuals with schizophrenia or schizoaffective disorder was terminated, and…
-
FDA approval · 2023-04-26FDA Approved: CLOZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Clozapine filed by Mylan Pharmaceuticals Inc., enabling continued generic availability under…
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: Feasibility Electrical Stimulation Study for Visual Hallucinations [NA]
A completed feasibility study evaluating electrical stimulation for visual hallucinations in schizophrenia, schizoaffective disorder, and bi…
-
FDA approval · 2023-03-01FDA Approved: PALIPERIDONE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' supplemental application to bring a generic paliperidone product to market.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: A Multiple Dose Study to Assess the Safety, Tolerability and PK of Risperidone Extended Release Capsules [Phase 2]
A Phase 2 multiple-dose study evaluated safety, tolerability, and pharmacokinetics of risperidone extended-release capsules in schizophrenia…
-
CLINICAL_TRIALS trial_result · 2022-12-30Clinical Trial Update: Targeting Cerebellum to Treat Psychosis: a Transcranial Magnetic Stimulation (TMS) Study [NA]
A completed clinical trial evaluating transcranial magnetic stimulation targeting the cerebellum for schizophrenia-related psychosis with re…
-
CLINICAL_TRIALS trial_result · 2022-12-21Clinical Trial Update: Restoration of Cognitive Function With TDCS and Training in Serious Mental Illness [NA]
Completed clinical trial investigating transcranial direct current stimulation (TDCS) plus training to restore cognitive function in serious…
-
CLINICAL_TRIALS trial_result · 2022-12-21Clinical Trial Update: Memantine Effects on Sensorimotor Gating and Neurocognition in Schizophrenia [Phase 4]
Phase 4 trial update on memantine's effects for sensorimotor gating and neurocognition in schizophrenia.
-
CLINICAL_TRIALS trial_result · 2022-11-22Clinical Trial Update: Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients [Phase 4]
A Phase 4 trial evaluating a fixed-dose intervention to enhance survival in patients with serious mental illness, including schizophrenia an…
-
CLINICAL_TRIALS research · 2022-11-21Clinical Trial Update: Virtual Reality Job Interview Training in Severe Mental Illness [NA]
A completed clinical trial evaluating virtual reality job interview training for individuals with severe mental illness, including schizophr…